Combination of Danshen and Renshen Regulates MDSCs to Remodel the Immune Microenvironment of Melanoma

YANG Ge-jun; ZOU Jue-yao; ZHAO Han; CHEN Qiong; HE Yong; LU Yin; CHEN Wen-xing

doi:10.14148/j.issn.1672-0482.2022.0717

Volume 38 Issue 8

Aug. 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Nanjing University of traditional Chinese Medicine > 2022 > 38(8): 717-726

YANG Ge-jun, ZOU Jue-yao, ZHAO Han, CHEN Qiong, HE Yong, LU Yin, CHEN Wen-xing. Combination of Danshen and Renshen Regulates MDSCs to Remodel the Immune Microenvironment of Melanoma[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(8): 717-726. doi: 10.14148/j.issn.1672-0482.2022.0717

Citation:

YANG Ge-jun, ZOU Jue-yao, ZHAO Han, CHEN Qiong, HE Yong, LU Yin, CHEN Wen-xing. Combination of Danshen and Renshen Regulates MDSCs to Remodel the Immune Microenvironment of Melanoma[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(8): 717-726. doi: 10.14148/j.issn.1672-0482.2022.0717

Citation:

YANG Ge-jun, ZOU Jue-yao, ZHAO Han, CHEN Qiong, HE Yong, LU Yin, CHEN Wen-xing. Combination of Danshen and Renshen Regulates MDSCs to Remodel the Immune Microenvironment of Melanoma[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(8): 717-726. doi: 10.14148/j.issn.1672-0482.2022.0717

PDF( 6135 KB)

Combination of Danshen and Renshen Regulates MDSCs to Remodel the Immune Microenvironment of Melanoma

doi: 10.14148/j.issn.1672-0482.2022.0717

YANG Ge-jun^1
,,
ZOU Jue-yao¹,
ZHAO Han¹,
CHEN Qiong¹,
HE Yong¹,
LU Yin^{1, 2},
CHEN Wen-xing^{1, 2
,
,}

1.
Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
2.
Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China

Received Date: 2022-04-02
Available Online: 2022-08-05

Abstract

Abstract

OBJECTIVE To observe the effect of the combination of Danshen and Renshen on the immune microenvironment of mouse melanoma cell line B16F10 in vivo and in vitro and its mechanism of inhibiting B16F10 blood metastasis. METHODS T-lymphocyte-B16F10 co-culture system was constructed in vitro. Flow cytometry was used to detect whether the combination of Danshen and Renshen could enhance the killing ability of T-lymphocytes against B16F10 in vitro. The model of B16F10 mouse tail vein blood metastasis was established. The inhibitory effect of the combination of Danshen and Renshen on B16F10 lung metastasis was observed by in vivo imaging and HE pathological staining. In addition, flow cytometry, immunohistochemistry and immunofluorescence techniques were used to detect the number of CD4⁺, CD8⁺T cells and MDSCs in tumor-bearing mice, and qPCR was used to detect the mRNA expression level related to the proliferation of MDSCs. RESULTS The combination of Danshen and Renshen could enhance the killing ability of T lymphocytes against tumor cells in vitro, and effectively inhibit B16F10 lung metastasis in mice, and enhance CD4⁺and CD8⁺T cell infiltration, which in turn suppressed the number of MDSCs in metastases by inhibiting the mRNA expression of MDSCs proliferation-related cytokines. CONCLUSION The combination of Danshen and Renshen can inhibit tumor metastasis by regulating MDSCs to reshape the immune microenvironment of melanoma. This study lays a foundation for the clinical application of the combination of Danshen and Renshen against tumor metastasis.
- combination of Danshen and Renshen,
- melanoma metastasis,
- MDSCs,
- immune microenvironment

FullText(HTML)

References(22)

References

[1]	SIEGEL RL, MILLER KD, FUCHS HE, et al. Cancer statistics, 2022[J]. CA A Cancer J Clin, 2022, 72(1): 7-33. doi: 10.3322/caac.21708
[2]	莫琼, 郝二伟, 覃文慧, 等. 平性活血化瘀中药物质基础与药理作用的研究进展[J]. 中国实验方剂学杂志, 2020, 26(1): 205-216. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202001031.htm MO Q, HAO EW, QIN WH, et al. Pharmacological effect and substance basis of neutral blood-activating and stasis-removing traditional Chinese medicine[J]. Chin J Exp Tradit Med Formulae, 2020, 26(1): 205-216. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202001031.htm
[3]	卢泰成, 李杰, 朱广辉, 等. 基于免疫重塑探讨活血药、益气活血药对肿瘤转移影响差异[J]. 中国中药杂志, 2021, 46(11): 2766-2772. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202111019.htm LU TC, LI J, ZHU GH, et al. Study on difference of effect of Huoxue drugs and Yiqi Huoxue drugs on tumor metastasis based on immune remodeling[J]. China J Chin Mater Med, 2021, 46(11): 2766-2772. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZY202111019.htm
[4]	HANAHAN D, WEINBERG RA. Hallmarks of cancer: The next generation[J]. Cell, 2011, 144(5): 646-674. doi: 10.1016/j.cell.2011.02.013
[5]	汤钊猷. "控癌战"而非"抗癌战"[J]. 世界科学, 2018(2): 32-34. doi: 10.3969/j.issn.1000-0968.2018.02.015 TANG ZY. "Cancer Control War" instead of "Anti-Cancer War"[J]. World Sci, 2018(2): 32-34. doi: 10.3969/j.issn.1000-0968.2018.02.015
[6]	MCALLISTER SS, WEINBERG RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis[J]. Nat Cell Biol, 2014, 16(8): 717-727. doi: 10.1038/ncb3015
[7]	TAKKENKAMP TJ, JALVING M, HOOGWATER FJH, et al. The immune tumour microenvironment of neuroendocrine tumours and its implications for immune checkpoint inhibitors[J]. Endocr Relat Cancer, 2020, 27(9): R329-R343. doi: 10.1530/ERC-20-0113
[8]	HOFER F, DI SARIO G, MUSIU C, et al. A complex metabolic network confers immunosuppressive functions to myeloid-derived suppressor cells (MDSCs) within the tumour microenvironment[J]. Cells, 2021, 10(10): 2700. doi: 10.3390/cells10102700
[9]	GAO XD, SUI HS, ZHAO S, et al. Immunotherapy targeting myeloid-derived suppressor cells (MDSCs) in tumor microenvironment[J]. Front Immunol, 2021, 11: 585214. doi: 10.3389/fimmu.2020.585214
[10]	TROVATO R, FIORE A, SARTORI S, et al. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3[J]. J Immunotherapy Cancer, 2019, 7: 255. doi: 10.1186/s40425-019-0734-6
[11]	XIA JX, MA SJ, ZHU X, et al. Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches[J]. Sci Adv, 2022, 8(6): eabj1262. doi: 10.1126/sciadv.abj1262
[12]	AKHTER KF, MUMIN MA, LUI EMK, et al. Transdermal nanotherapeutics: Panax quinquefolium polysaccharide nanoparticles attenuate UVB-induced skin cancer[J]. Int J Biol Macromol, 2021, 181: 221-231. doi: 10.1016/j.ijbiomac.2021.03.122
[13]	PILATOVA K, BENCSIKOVA B, DEMLOVA R, et al. Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: Considerations for granulocyte colony-stimulating factor treatment[J]. Cancer Immunol Immunother, 2018, 67(12): 1919-1929. doi: 10.1007/s00262-018-2166-4
[14]	卞国良, 李君佩, 赵振伟. 一种增加骨密度的药物组合物及其制备方法: CN106310034A[P]. 2016-10-18. BIAN GL, LI JP, ZHAO ZW. A pharmaceutical composition for increasing bone density and its preparation method: CN106310034A[P]. 2016-10-18.
[15]	DAABOUL HE, DAGHER C, TALEB RI, et al. The chemotherapeutic effect of β-2-himachalen-6-ol in chemically induced skin tumorigenesis[J]. Biomed Pharmacother, 2018, 103: 443-452. doi: 10.1016/j.biopha.2018.04.027
[16]	LIU YL, BAGER CL, WILLUMSEN N, et al. Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer[J]. Npj Breast Cancer, 2021, 7: 108. doi: 10.1038/s41523-021-00313-w
[17]	KONG J, TIAN HZ, ZHANG FY, et al. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts[J]. Mol Cancer, 2019, 18: 175.
[18]	LI R, WEN AN, LIN J. Pro-inflammatory cytokines in the formation of the pre-metastatic niche[J]. Cancers, 2020, 12(12): 3752. doi: 10.3390/cancers12123752
[19]	JUNTTILA MR, DE SAUVAGE FJ. Influence of tumour micro-environment heterogeneity on therapeutic response[J]. Nature, 2013, 501(7467): 346-354.
[20]	CARBONE M, ARRON ST, BEUTLER B, et al. Tumour predisposition and cancer syndromes as models to study gene-environment interactions[J]. Nat Rev Cancer, 2020, 20(9): 533-549.
[21]	GROTH C, ARPINATI L, SHAUL ME, et al. Blocking migration of polymorphonuclear myeloid-derived suppressor cells inhibits mouse melanoma progression[J]. Cancers, 2021, 13(4): 726.
[22]	JIMÉNEZ-CORTEGANA C, PALAZÓN-CARRIÓN N, MARTIN GARCIA-SANCHO A, et al. Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: Translational results from the R2-GDP-GOTEL trial[J]. J Immunother Cancer, 2021, 9(6): e002323.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(9) / Tables(1)

Get Citation

PDF

XML

Article Metrics

Article views (203) PDF downloads(17)

Combination of Danshen and Renshen Regulates MDSCs to Remodel the Immune Microenvironment of Melanoma

doi: 10.14148/j.issn.1672-0482.2022.0717

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Combination of Danshen and Renshen Regulates MDSCs to Remodel the Immune Microenvironment of Melanoma

doi: 10.14148/j.issn.1672-0482.2022.0717

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content